2018 Publications

Penn C, Yang K, Zhang H, Lim J, Baker JR Jr, Goonewardena S, Buckanovich R. Therapeutic Impact of Nanoparticle Therapy Targeting Tumor Associate Macrophages. Mol Cancer Ther. 2018 Jan;17(1):96-106. doi: 10.1158/1535-7163.MCT-17-0688.  PMID: 29133618

Hill EE, Kim JK, Jung Y, Neeley CK, Pienta KJ, Taichman RS, Nor JE, Baker JR Jr., Krebsbach PH. Integrin Alpha V Beta 3 Targeted Dendrimer-Rapamycin Conjugate Reduces Fibroblast-Mediated Prostate Tumor Progression and Metastasis. J Cell Biochem. 2018 Jan 30. doi: 10.1002/jcb.26727.  PMID: 29380900

O'Konek JJ, Landers JJ, Janczak KW, Goel RR, Mondrusov AM, Wong PT, Baker JR Jr. Nanoemulsion adjuvant-driven redirection of TH2 immunity inhibits allergic reactions in murine models of peanut allergy. J Allergy Clin Immunol. 2018 June; 141(6): 2121-2131. 

Bowden S, Joseph C, Tang S, Cannon J, Francis E, Zhou M, Baker JR Jr., Choi SK. Oritavancin Retains a High Affinity for a Vancomycin-Resistant Cell-Wall Precursor via its Bivalent Motifs of Interaction.  Biochemistry 2018 May 8; 57(18): 2723-2732. 
Comments